Skip to content

Clinical trials

Phase 4 Macular Degeneration trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 4 Status: Unknown status Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20101
20123
20132
20141
20151
20162
20172
20182
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tennessee Retina2
Unity Health Toronto2
Benha University1
Brigham and Women's Hospital1
Eyetech Pharmaceuticals1
Hadassah Medical Organization1
Kagawa University1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Osias Francisco de Souza1
Retina Research Institute, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration17
Macular Edema2
Retinal Vein Occlusion2
Cataract1
Central Serous Chorioretinopathy1
Retinal Detachment1
Retinal Dystrophies1
Wet Macular Degeneration1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.